Carboxylesterase (CES) is important for detoxification of a wide range of drugs and xenobiotics and catalyzes cholesterol and fatty acid metabolism. Cynomolgus macaques are widely used in drug metabolism studies; however, cynomolgus CES has not been fully investigated at molecular levels, partly due to the lack of gene information. In this study, we isolated and characterized cDNAs for CES homologous to human CES1, CES2, and CES5A in cynomolgus macaques. By genome analysis, in the cynomolgus macaque genome, three gene sequences were found for CES1(v1-3) and CES2(v1-3), whereas one gene sequence was found for CES5A. Cynomolgus CES1, CES2, and CES5A genes were located in the genomic regions corresponding to the human genes. We successfully identified CES1v1, CES1v2, CES2v1, CES2v3, and CES5A cDNAs from cynomolgus liver. Sequence analysis showed that amino acid sequences of each CES were highly homologous to that of the human homolog. All five CESs had sequences characteristic for CES enzymes, including the catalytic triad and oxyanion hole loop. By quantitative polymerase chain reaction, the most abundant expression of CES mRNAs among the 10 tissue types analyzed was observed in liver (CES1v1 and CES2v3 mRNAs), jejunum (CES2v1 mRNAs), and kidney (CES1v2 and CES5A mRNA), the organs important for drug metabolism and excretion. The results indicated that cynomolgus macaques express at least five CES genes, which potentially encode intact CES proteins.
Introduction
Carboxylesterase (CES; E.C. 3.1.1.1), a member of the serine esterase superfamily, is responsible for hydrolysis of various xenobiotic and endogenous esters (Hosokawa, 2008) . They are important for the detoxification of foreign ester-or amide-bond-containing substances, such as cocaine, heroin, 6-monoacetylmorphine, lidocaine, and butanilicaine (Hosokawa et al., 1987; Alexson et al., 2002; Hosokawa, 2008) . CES is a gene family comprising at least six members, including CES1, CES2, CES3, CES4, CES5, and CES6 in humans (Holmes et al., 2010) , among which CES1 and CES2 are largely important for metabolism of drugs, such as angiotensin-converting enzyme inhibitor (temocapril) and antitumor drug (irinotecan) (Hosokawa, 2008) . In humans, two major CES isoforms, CES1 and CES2, have been identified in liver (Imai, 2006) . CES2 is also expressed in the extrahepatic tissues, including small intestine (Xu et al., 2002) , where CES2 is considered as a major CES isoform in humans (Imai, 2006) . CES5A was found as a major urinary protein in feline urine, secreted from kidney (Miyazaki et al., 2006) , and human CES5A mRNA is also expressed in kidney (Holmes et al., 2008) .
Cynomolgus macaques are frequently used in preclinical studies due to their evolutionary closeness to humans. In cynomolgus macaques, drug-metabolizing properties of CES enzymes have been characterized using human CES1 and CES2 substrates with liver and small intestine microsomes (Taketani et al., 2007) . In cynomolgus macaques, one CES1 cDNA and one CES2 cDNA were used to prepare recombinant proteins, which were expressed to assess their drug-metabolizing capabilities (Williams et al., 2011) . In the genome of rhesus macaques (closely related to cynomolgus macaques), three CES1 and three CES2 genes are present (Williams et al., 2010) , raising the possibility that other CES1 and CES2 genes are present in the cynomolgus genome. To understand cynomolgus CES isoforms at the molecular level, it is important to identify and characterize the CES genes in the genome.
In this study, cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A cDNAs were identified based on the cynomolgus genome data. Molecular characteristics of these cynomolgus CESs were investigated by analysis of genomic organization, gene structure, primary sequence structure, and phylogeny. Tissue expression patterns were determined by quantitative polymerase chain reaction (qPCR).
Materials and Methods
Tissue Samples and RNA Extraction. Tissue samples were collected from which total RNA was prepared as previously described (Uno et al., 2006) . Briefly, brain, lung, heart, liver, kidney, adrenal gland, small intestine (jejunum), testis, ovary, and uterus were collected from six cynomolgus macaques (three males and three females from Indochina, 4-5 years of age, 3-5 kg) and were quickly frozen to prevent possible RNA degradation. Total RNA was extracted from each sample using RNeasy Mini Kit, according to the manufacturer's protocol, including DNase I treatment. The study was reviewed and approved by the Institutional Animal Care and Use Committee at Shin Nippon Biomedical Laboratories (Kainan).
Isolation of Cynomolgus CES cDNAs. Reverse transcription (RT)-polymerase chain reaction (PCR) was performed, as previously described (Uno et al., 2006) , using total RNA from cynomolgus macaque liver, jejunum, or kidney. Briefly, the firststrand cDNA was generated in a mixture containing 1 mg total RNA, oligo(dT), and SuperScript III RT reverse transcriptase (Invitrogen, Carlsbad, CA) at 50°C for 1 hour. The generated cDNA was used as a template for the subsequent PCR that was carried out with Platinum PCR SuperMix High Fidelity (Invitrogen), according to the manufacturer's protocol. PCR conditions included an initial denaturation at 94°C for 1 minute and 30 cycles of 94°C for 30 seconds, 58°C for 30 seconds, and 68°C for 2 minutes, followed by a final extension at 68°C for 5 minutes. The primers used were mmCES1v1(5rt1) 59-GAAAACTGTCGCCCTTCCAC-39 and mmCES1v1(3rt1) 59-ACTTTATTCCCAAAGCTGAGGTC-39 for CES1v1 and CES1v2, mmCES2v1(5rt1) 59-AGGACTGGTTTGAAGAGAGGATTC-39 and mmCES2v1(3rt1) 59-GGCTAAGTGAATGAAGGAATCAA-39 for mfCES2v1, mmCES2v1(5rt1) and mmCES2v3(3rt1) 59-GCCTGTAAGCGAGCCTAACCT-39 for mfCES2v3, and mmCES7v1(5rt1) 59-GAACGAAGTTCTCTGAGGCCAA-39 and mmCES7v1(3rt1) 59-TCCATAAGGATCATTCCTAAGTCC-39 for CES5A. The amplified PCR products were cloned into pGEM-T Easy vectors using pGEM-T Easy Vector Systems (Promega, Madison, WI), according to the manufacturer's protocols. The inserts were sequenced using ABI Prism BigDye Terminator v3.0 Ready Reaction Cycle Sequencing Kit (Applied Biosystems, Foster City, CA), followed by electrophoresis with an ABI PRISM 3730 DNA Analyzer (Applied Biosystems).
Sequence Analysis. Raw sequence data were analyzed using DNASIS Pro (Hitachi Software, Tokyo, Japan) and Genetyx system (Software Development, Tokyo, Japan). Multiple alignment of amino acid sequences was carried out using the ClustalW program, and a phylogenetic tree was created by the neighborjoining method. A homology search was performed using BLAST available at the National Center for Biotechnology Information website (http://ncbi.nlm.nih.gov/). The human and cynomolgus macaque genome data were analyzed using BLAT available at the UCSC Genome Bioinformatics website (http://genome.ucsc.edu/) and Sequence Viewer (http://ncbi.nlm.nih.gov/). Amino acid sequences used were from GenBank, including human AADAC (NP_001077), CES1c (NP_001257), CES2v1 (NP_003860), and CES5Av1 (NP_001137157); dog CES1 (NP_001003085) and CES5A (NP_001003085); rat Ces1a (NP_001177304), Ces1c (NP_058700), Ces1d (NP_579829), Ces1e (NP_113753), Ces1f (NP_001096829), Ces2a (NP_653344), Ces2c (NP_598270), Ces2e (NP_001093947), Ces2h (NP_001037723), Ces2j (NP_001177309), and Ces5a (NP_001012056); and from this study, including cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A. The cDNA sequences used were from GenBank, including human CES1v3 (NM_001266), CES2v1 (NM_003869), and CES5Av1 (NM_001143685); and from this study, we included cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A.
Measurement of mRNA Expression. Expression of cynomolgus CES mRNAs was measured by qPCR, as previously reported (Uno et al., 2006) , with the following modifications. A twenty-fifth volume of RT product was used for the subsequent PCR that was carried out in a total volume of 25 ml using SYBR Green PCR Master Mix (Applied Biosystems) with the ABI Prism 7500 sequence detection system (Applied Biosystems), according to the manufacturer's protocol. Standard curves constructed by serial 10-fold dilutions (10 2 to 10 7 copies) were used to calculate expression level for each mRNA, and expression levels ,10 2 copies were considered to be below the detection limit. Relative expression level was determined by normalization of the raw data to b-actin level based on three independent amplifications. The primers were mfCES1v1(5qrt1) 59-TTGGAGACAACATTGAAAATGAAA-39 and mfCES1v1(3qrt1) 59-TCAATCACGGTGCCCAAG-39 for cynomolgus CES1v1, mfCES1v2(5qrt1) 59-GGAGACGACATTGAAAACGATG-39 and mfCES1v2(3qrt1) 59-CCCATCAATCACGGTGGTAA-39 for cynomolgus CES1v2, mfCES2v(5qrt1) 59-CCAATCTGTCAGCCTGTGG-39 and mfCES2v(3qrt1) 59-GGAAGAT-CCCATCCACCACT-39 for cynomolgus CES2v1, mfCES2v3(5ex5a) 59-CCAGCCTGTCTGCTTGTGAG-39 and mfCES2v3(3ex6a) 59-GGAA-GACCCCATCGACTACA-39 for cynomolgus CES2v3, mf&hCES7(5qrt3) 59-GATCCTCAGTGGCTCCAACA-39 and mf&hCES7(3qrt3) 59-CATTAG-CCACAAGGTGCAAATAC-39 for cynomolgus CES5A, and h&mfBeta-actin (5qrt1) 59-GGAAATCGTGCGTGACATT-39 and h&mfBeta-actin(3qrt1) 59-TTTCGTGGATGCCACAGG-39 for b-actin. Each primer was used at a final concentration of 600 nM, except for b-actin primers (300 nM).
Results
Genomic Organization of Cynomolgus CES Genes. The analysis of the cynomolgus genome data using Sequence Viewer found three CES1(v1-3) and three CES2(v1-3) gene sequences in the genome, unlike humans, that had three CES1 genes and one CES2 gene (Supplemental Fig. 1 ). A single gene sequence was found in the cynomolgus macaque genome for CES5A, similar to humans (Supplemental Fig. 1 ). Cynomolgus CES1, CES2, and CES5A genes were on the same chromosome (20); CES1 and CES5A genes together form the gene cluster, and three CES2 genes form another gene cluster. The CES1/CES5A gene cluster was flanked by SLC6A2 and GNAO1, whereas the CES2 gene cluster was flanked by FAM96B and CBFB, similar to humans. Therefore, these cynomolgus CES genes were located in the genomic regions corresponding to the human homologs, suggesting similarities in the genomic organization of the CES genes between cynomolgus macaques and humans.
Analysis of Cynomolgus CES Sequences. For the cynomolgus CES gene sequences, we attempted to isolate the cDNAs by RT-PCR. Cynomolgus CES1v1 and CES2v3 cDNAs were successfully isolated from liver, CES2v1 cDNA was from jejunum, and CES1v2 and CES5A cDNAs were from kidney. In contrast, the cDNAs for CES1v3 and CES2v2 were not amplified in the conditions used in this study. Deduced amino acid sequences of cynomolgus CES1v1/v2, CES2v1/v3, and CES5A had high sequence identities (88-96%) to human CES1, CES2, and CES5A, respectively (Table 1) . Cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A cDNA sequences identified in this study were deposited to GenBank under accession numbers KJ922597, KJ922598, KJ922599, KJ922600, and KJ922602, respectively. A phylogenetic tree created using CES amino acid sequences of humans, cynomolgus macaques, dogs, and rats showed that cynomolgus CES1v1/v2, CES2v1/v3, and CES5A were most closely clustered with human CES1, CES2, and CES5A, respectively (Fig. 1) . These results suggest the evolutionary closeness of CES isoforms between cynomolgus macaques and humans.
Cynomolgus CES1v1/v2 contained 567 amino acid residues with the primary sequence characteristics of CES proteins, including signal peptide sequences, microsomal targeting signals, active site triad residues, disulfide bond Cys residues, Z site, and Gate, similar to human CES1, which were also found in the matured form of human CES2 and cynomolgus CES2v3 (561 amino acid residues) (Supplemental Fig. 2) . In contrast, cynomolgus CES2v1 contained a shorter open reading frame (485 amino acid residues), lacking the signal peptide in the N terminus and the microsomal targeting sequences in the C terminus ( Supplemental Fig. 2 ). Cynomolgus CES2v1 also lacked one of the four disulfide bond Cys residues due to the lack of the N terminus, but retained other sequence characteristics, including active site triad residues. Cynomolgus CES5A contained 581 amino acid residues, including the extra 6 residues in the C terminus as compared with human CES5A (Supplemental Fig. 2 ). Cynomolgus CES5A contained signal peptide sequences, active site triad residues, Z site, and Gate, and three of the four disulfide bond Cys residues, but lacked microsomal targeting signals, similar to human CES5A. Two cynomolgus CES5A transcript variants were identified. Transcript variant 1 contained the nonsense mutation (W205X, c.615G.A) (Supplemental Fig. 2) , which would be translated into the truncated protein due to the premature termination codon. Transcript variant 2 lacked Glu475 (Supplemental Fig. 2) due to 3-base deletion (c.1424AAG.del). Moreover, cynomolgus CES1v1/v2, CES2v1/v3, and CES5A had 1, 1, and 3 potential N-glycosylation sites, respectively (Supplemental Fig. 2) . These results indicated that the cynomolgus CES1v1/v2, CES2v1/v3, Fig. 3 ). Among the cynomolgus CES genes analyzed, the largest was CES1v1 (;45.1 kb) and the smallest was CES2v1 (;3 kb). Cynomolgus CES1v2 and CES2v3 contained the same 14 and 12 coding exons as human CES1 and CES2, respectively. Cynomolgus CES1v1 exons 1-12 and 14 were found in the genome, but exon 13 was missing due to the gap between exons 12 and 14. All the cynomolgus CES1v1 and CES1v2 exons were the same sizes as the human CES1 exons. Similarly, cynomolgus CES2v3 exons were the same sizes as the human CES2 exons, except for the first and last exons, the latter of which was 190 bp, 3 bp larger than human CES2, resulting in 1 additional amino acid residue as compared with human CES2. In contrast, cynomolgus CES2v1 contained only 7 exons, likely accounting for the smaller gene size than human CES2 and cynomolgus CES2v3. Cynomolgus and human CES5A genes contained 13 coding exons with the same size of each exon, except for exon 13, which was 18 bp larger for cynomolgus CES5A than human CES5A, resulting in the extra 6 amino acid residues of cynomolgus CES5A protein. The introns of all these cynomolgus and human CES genes begin with the dinucleotide GU and end with AG, consistent with the consensus sequences for splice junctions in eukaryotic genes. These results indicated highly conserved gene structures of CES genes in cynomolgus macaques and humans, except for cynomolgus CES2v1, which was smaller than human CES2 with smaller numbers of exons.
Tissue Expression Pattern of Cynomolgus CES mRNAs. qPCR analysis was performed for cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A mRNA in brain, lung, heart, liver, kidney, adrenal gland, jejunum, testis, ovary, and uterus. Relative expression level normalized with b-actin level showed that cynomolgus CES1v1 mRNA was preferentially expressed in liver, but relatively abundant expression of CES1v2 mRNA was detected in liver, kidney, and jejunum (Table 2) . Cynomolgus CES2v1 mRNA was expressed abundantly in kidney and jejunum, and in liver to a lesser extent (Table 2) . Cynomolgus CES2v3 and CES5A mRNAs were expressed most abundantly in liver, followed by kidney, and expression of CES2v3 mRNA was also detected in jejunum to a lesser extent (Table 2) . Next, expression levels of cynomolgus CES mRNAs were compared in liver, jejunum, kidney, and lung. In liver, cynomolgus CES1v1 mRNA was most abundantly expressed among cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A mRNAs, followed by CES2v3 mRNA (Table 2 ). In jejunum, cynomolgus CES2v1 mRNA was most abundantly expressed, followed by CES1v2 and CES2v3 mRNAs. In kidney, cynomolgus CES2v3 mRNA was expressed most abundantly, followed by CES1v2, CES2v1, and CES1v1 mRNAs. In lung, cynomolgus CES1v1 mRNA was most abundantly expressed, followed by CES2v3 and CES1v2 mRNAs. The results indicated that, in liver, kidney, and jejunum, the organs important for drug metabolism, expression of cynomolgus CES mRNAs was abundant.
Discussion
CES enzymes are important for the detoxification of foreign esteror amide-bond-containing substances, such as cocaine, heroin, and 6-monoacetylmorphine. Despite the importance of CES in drug metabolism, CES has not been fully investigated in cynomolgus macaques, an essential nonhuman primate species for drug metabolism studies. In this study, we identified cynomolgus cDNAs highly homologous to human CES cDNAs, using the cynomolgus macaque genome data. Cynomolgus CES1v1/v2, CES2v1/v3, and CES5A had high amino acid sequence identities to human CES1, CES2, and CES5A, respectively (Table 1) , and each cynomolgus CES was more closely clustered with the human homolog than the dog or rat homolog in a phylogenetic tree (Fig. 1) . Cynomolgus CES1v1/v2, CES2v3, and CES5A contained the primary sequence structures characteristic of CES proteins, including signal peptide sequences, active site triad residues, disulfide bond Cys residues, Z site, Gate, and N-glycosylation site(s), along with the microsomal targeting sequence in the C terminus for cynomolgus CES1v1/v2 and CES2v3, similar to the human CES1 and CES2 ( Supplemental Fig. 2) . These results suggest that cynomolgus CES proteins are evolutionarily closer to the human CES proteins than the CES proteins of other species, such as dogs and rats, which are also used in drug metabolism studies.
In contrast to human CES2 and cynomolgus CES2v3, cynomolgus CES2v1 lacked the signal peptide in the N terminus and the microsomal targeting sequence in the C terminus, but retained other functional sequence features, such as active site triad residues, disulfide bond Cys residues, Z site, Gate, and N-glycosylation site ( Supplemental Fig. 2) . Cynomolgus CES2v1 might remain in the cytosol, and thus might not function properly in the cell, unlike human CES2 that translocates to the cell membrane with signal peptide after translation and to endoplasmic reticulum after use (Potter et al., 1998) . Alternatively, cynomolgus CES2v1 might be secreted in vivo, considering that site mutagenesis of human CES1 microsomal targeting sequence results in the secretion of the CES1 enzyme from the cell in vitro (Miller et al., 1999) . Moreover, feline CES5A, lacking the microsomal targeting sequence, is secreted into urine from kidney (Miyazaki et al., 2006) . It is of great interest to investigate whether cynomolgus CES2v1 functions as a secreted enzyme.
Species differences are observed for CES enzymes in terms of substrate specificity, metabolic activity, and the encoded genes. A large Fig. 1 . Phylogenetic tree of cynomolgus CES1v1, CES1v2, CES2v1, CES2v3, and CES5A amino acid sequences. The phylogenetic tree was created using the neighbor joining method, as described in Materials and Methods, using CES1, CES2, and CES5A amino acid sequences of humans (h), cynomolgus macaques (mf), dogs (d), and rats (r). Human AADAC amino acid sequence was used as outgroup.
number of the CES1 and CES2 genes in the rodent genome, including five CES1 genes and seven CES2 genes in rats, and eight CES1 genes and seven CES2 genes in mice, is potentially expressed with the complete coding regions (Holmes et al., 2010) . CES activity is found in horse, tiger, feline, rabbit, rat, and mouse plasma, but not in primate plasma (including cynomolgus macaques and humans) (Li et al., 2005; Williams et al., 2011) . Moreover, dogs appear to lack CES activity in small intestine, as shown by the lack of CES signals by immunoblotting (Taketani et al., 2007; Williams et al., 2011) . Therefore, animals need to be carefully selected to investigate a CES-dependent drug metabolism.
Substrate selectivity is one of the important factors responsible for species differences on a CES-dependent drug metabolism, but has not been adequately investigated in cynomolgus macaques. In humans, distinct substrate selectivity has been reported for CES1 and CES2 despite their similar sequence identities in amino acids (48%). CES1 catalyzes the hydrolysis of the compounds with large acyl group and small alcohol group to those with small acyl group, whereas CES2 hydrolyzes the compounds with a relatively small acyl group and large alcohol group (Pindel et al., 1997; Bosron and Hurley, 2002; Satoh et al., 2002; Imai, 2006) . Human CES1 contains a small, rigid pocket and the large, flexible pocket, which are selective and promiscuous substrate specificity, respectively, and thus CES1 can act on structurally distinct compounds containing either large or small alcohol moieties. Interestingly, cocaine is catalyzed by CES1 and CES2; the methyl ester of cocaine is hydrolyzed by CES1, producing benzoylecgonine and methanol, and the benzoyl ester of cocaine is hydrolyzed by CES2 (Pindel et al., 1997; Satoh et al., 2002; Imai, 2006; Hosokawa, 2008) .
We identified three CES1 genes and three CES2 genes in the cynomolgus genome (Supplemental Fig. 1 ). Multiple CES1 and CES2 genes have also been found in other species, including rats and mice (Holmes et al., 2010) . Cytochrome P450 family of drug-metabolizing enzymes has evolved by gene duplication and gene loss during evolution (Thomas, 2007) . Similarly, CES1 and CES2 genes might have evolved by gene duplication to increase their capability to detoxify diverse xenobiotics taken in diet. In contrast, the single gene of CES5A in various species (including cynomolgus macaques and humans) might reflect their role to metabolize mainly endogenous substrates.
A previous study reported identification of one CES1 cDNA and two CES2 cDNAs in cynomolgus macaques (Williams et al., 2010) , and the tissue expression patterns and catalytic activities analyzed using recombinant proteins were investigated for one CES1 protein (cCES1) and one CES2 (cCES2) protein (Williams et al., 2011) . Although the relation of the cynomolgus CES1 and CES2 analyzed between the first and second study was not clearly stated in the paper, information on the partial sequences shown allowed us to predict that cynomolgus CES1v1 and CES2v1 were analyzed as cCES1 and cCES2, respectively, in the second paper. Indeed, in that study, cCES1 mRNA was expressed abundantly in liver, and in kidney to a much lesser extent (Williams et al., 2011) , similar to cynomolgus CES1v1 (Table 2) . However, cCES2 mRNA was abundantly expressed in liver and jejunum (Williams et al., 2011) , unlike cynomolgus CES2v1 and CES3v3 mRNA (Table 2) . Interestingly, our attempts failed to isolate cynomolgus CES2v2 cDNA from liver, probably due to the different experimental conditions used, such as primers. Alternatively, cynomolgus CES2v2 might be expressed, depending on the animal or the origin. It is of great interest to investigate all these CES1 and CES2 enzymes to assess the contribution of each enzyme to total CES activity in cynomolgus liver and small intestine.
In conclusion, cynomolgus CES1v1/v2, CES2v1/v3, and CES5A, highly homologous to human CES1, CES2, and CES5A, respectively, were identified in this study. Sequence analysis showed the sequence similarity of these cynomolgus proteins to the human homologs more than the dog or rat homologs. Cynomolgus CES1v1/v2, CES2v1/v3, and CES5A had most of the sequence characteristics of human CES enzymes. Cynomolgus CES1v1/v2, CES2v1/v3, and CES5A mRNAs showed distinct tissue expression patterns with relatively abundant expression in liver, jejunum, and/or kidney, the drug-metabolizing organs, similar to the human homologs, most likely reflecting their roles as drugmetabolizing enzymes. The results suggest overall molecular similarities of CES enzymes in cynomolgus macaques and humans.
